IP Verse

Concert Pharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Methods For Treating Hair Loss Disorders

Applicant:

Opposition Date:

Apr 30, 2020

Patent Number:

Title:

Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase Inhibitor

Applicant:

Opposition Date:

Jun 28, 2019

Patent:

Grant Date:

Feb 24, 2021

Title:

Deuterated Derivatives Of Ruxolitinib

Oppositions:

Patent Number	Title	Applicant	Opposition Date
EP2635299	Methods For Treating Hair Loss Disorders	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	Apr 30, 2020
EP3184526	Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase Inhibitor	INCYTE HOLDINGS CORPORATION	Jun 28, 2019

Patent Number	Grant Date	Title	Total Oppositions
EP3450434	Feb 24, 2021	Deuterated Derivatives Of Ruxolitinib	1

INCYTE CORPORATION

INCYTE HOLDINGS CORPORATION

THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

Feel free to send us a message here and we will get back to you